Featuring: Patrick Leung, CTO, Faro Health Inc.
Abstract: In this webinar, the expert speaker will discuss key trends in the adoption of artificial intelligence (AI) for clinical development teams in biopharma and share insights into how organizations can set themselves up for success in implementing novel technologies to accelerate clinical protocol development without compromising on quality.
Clinical trial protocol documents are both critically important and highly complex. General-purpose AI models are typically unable to produce generated protocol content that is of sufficiently high quality and free of errors and hallucinations. To solve this problem, AI models need to incorporate the power of a detailed, structured data model specific to the clinical trial domain. By building or leveraging such a domain model, it is now possible to author protocol documents in a fraction of the time that it would historically take without such tools.
Register for this webinar to learn more about how organizations can apply AI for the clinical protocol development process, critically evaluate AI-based solutions to ensure they are fit for purpose and how organizations can be set up for success by adopting tools to accelerate clinical development.
What You Will Learn:
- Key trends in the adoption and use of AI in clinical development
- Critical criteria by which AI-based solutions should be evaluated for use in clinical development
- Success factors for organizations hoping to adopt or implement novel AI solutions
- How fit-for-purpose, high-quality generative AI models are being implemented for protocol development